Mitsuhiro Yokoyama
Overview
Explore the profile of Mitsuhiro Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
4357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Itakura H, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, et al.
J Atheroscler Thromb
. 2012 Jun;
19(7):673-9.
PMID: 22653220
Aim: The Japan EPA Lipid Intervention Study (JELIS) reported a 19% reduction of the risk for coronary artery disease after long-term use of pure eicosapentaenoic acid (EPA) in Japanese patients...
12.
Takaya T, Yamada S, Ryo K, Mukohara N, Yokoyama M
Eur Heart J Cardiovasc Imaging
. 2012 Apr;
13(9):800.
PMID: 22518052
No abstract available.
13.
Sasaki J, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, et al.
J Atheroscler Thromb
. 2011 Dec;
19(2):194-204.
PMID: 22186099
Aim: The present study examined the importance of reducing non-high-density lipoprotein cholesterol (non-HDL-C) for the primary prevention of the occurrence of coronary artery disease (CAD) in the JELIS, and the...
14.
Sawada T, Emoto T, Motoji Y, Hashimoto M, Kageyama H, Terashita D, et al.
Int J Cardiol
. 2011 Dec;
166(3):613-20.
PMID: 22172589
Background: Despite being a relatively widely-used non-invasive parameter of endothelial dysfunction, little is known regarding the relationship between flow-mediated dilatation (FMD) and coronary plaque vulnerability in patients with coronary artery...
15.
Emoto T, Sawada T, Hashimoto M, Kageyama H, Terashita D, Mizoguchi T, et al.
Am J Cardiol
. 2011 Sep;
109(1):42-6.
PMID: 21944671
Repeated postprandial hyperglycemia may play an important role in the development of atherosclerosis by suppressing vascular endothelial function. Although miglitol suppresses the elevation of blood glucose levels shortly after a...
16.
Watanabe S, Shite J, Takaoka H, Shinke T, Tanino Y, Otake H, et al.
J Cardiol
. 2011 Aug;
58(3):245-52.
PMID: 21862290
Objectives: This study was designed to determine the prognostic importance of left ventricular (LV) myocardial stiffness, a hemodynamic index which is closely related to B-type natriuretic peptide (BNP) concentration in...
17.
Nakajima K, Yamashita T, Kita T, Takeda M, Sasaki N, Kasahara K, et al.
Arterioscler Thromb Vasc Biol
. 2011 Aug;
31(9):1963-72.
PMID: 21817104
Objective: Eicosapentaenoic acid (EPA) has been shown to have beneficial effects on cardiovascular diseases, although the precise mechanism is unknown. We investigated the effect of EPA on the regression of...
18.
Tanaka S, Miki T, Sha S, Hirata K, Ishikawa Y, Yokoyama M
J Atheroscler Thromb
. 2011 Mar;
18(7):584-91.
PMID: 21427508
Aim: Evidence of relationships between lipid peroxidation and the incidence of coronary heart disease is limited. We therefore investigated this association in a Japanese general population. Methods: We prospectively studied...
19.
Itakura H, Yokoyama M, Matsuzaki M, Saito Y, Origasa H, Ishikawa Y, et al.
J Atheroscler Thromb
. 2010 Nov;
18(2):99-107.
PMID: 21099130
Aim: The Japan EPA Lipid Intervention Study (JELIS) was the first prospective randomized clinical trial to demonstrate prevention of coronary events by pure eicosapentaenoic acid (EPA). The aim of this...
20.
Ishikawa Y, Yokoyama M, Saito Y, Matsuzaki M, Origasa H, Oikawa S, et al.
Circ J
. 2010 May;
74(7):1451-7.
PMID: 20484828
Background: The JELIS trial examined the preventive effects of eicosapentaenoic acid (EPA) on coronary artery disease (CAD) in hypercholesterolemia. Previous investigators have reported that patients with peripheral artery disease (PAD)...